Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep;65(9):352-372.
doi: 10.1111/1348-0421.12916. Epub 2021 Aug 21.

Current situation of viral hepatitis in Egypt

Ashraf Elbahrawy  1 , Marwa K Ibrahim  2   3 , Ahmed Eliwa  1 , Mohamed Alboraie  1 , Ali Madian  4 , Hussein Hassan Aly  3
Affiliations
Free article
Review

Current situation of viral hepatitis in Egypt

Ashraf Elbahrawy et al. Microbiol Immunol. 2021 Sep.
Free article

Abstract

An estimated 8-10 million people suffer from viral hepatitis in Egypt. Hepatitis A virus (HAV) and hepatitis E virus (HEV) are the major causes of viral hepatitis in Egypt as 50% or more of the Egyptian population are already exposed to HAV infection by the age of 15. In addition, over 60% of the Egyptian population test seropositive for anti-HEV in the first decade of life. HEV mainly causes self-limiting hepatitis; however, cases of fulminant hepatitis and liver failure were reported in Egypt. Hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis D virus (HDV) are the main causes of chronic hepatitis, liver cirrhosis, and liver cancer (hepatocellular carcinoma [HCC]) in Egypt. Globally, Egypt had the highest age-standardized death rate due to cirrhosis from 1990 to 2017. The prevalence rate of HBV (1.3%-1.5%) has declined after national infantile immunization. Coinfection of HBV patients with HDV is common in Egypt because HDV antibodies (IgG) vary in range from 8.3% to 43% among total HBV patients. After the conduction of multiple national programs to control HCV infection, a lower rate of HCV prevalence (4.6%) was recently reported. Data about the incidence of HCV after treatment with direct antiviral agents (DAAs) are lacking. An HCC incidence of 29/1000/year in cirrhotic patients after DAA treatment is reported. A higher rate of infiltrative pattern among HCC patients after DAA treatment is also recognized. Viral hepatitis is one of the major public health concerns in Egypt that needs more attention and funding from health policymakers.

Keywords: Egypt; hepatitis A virus; hepatitis B virus; hepatitis C virus; hepatitis D virus; hepatitis E virus.

PubMed Disclaimer

References

REFERENCES

    1. Stanaway JD, Flaxman AD, Naghavi M, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet. 2016;388(10049):1081-8.
    1. Centers for Disease, Control and Prevention. Progress toward prevention and control of hepatitis C virus infection-Egypt, 2001-2012. MMWR. 2012;61(29):545-9.
    1. Ministry of Health and Population (MOHP). Plan of Action for the Prevention, Care & Treatment of Viral Hepatitis. Egypt 2014-2018. (Available at:) http://www.emro.who.int/images/stories/egypt/VH_Plan_of_Action_FINAL_PRI.... Accessed January 11, 2021.
    1. Deuffic-Burban S, Mohamed MK, Larouze B, Carrat F, Valleron AJ. Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections. J Hepatol. 2006;44(3):455-61.
    1. Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology. 2012;55:988-97.

MeSH terms

Substances

LinkOut - more resources